2002 Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases

Thursday, July 18, 2002
The National Press Club, First Amendment Room
529 14th Street, NW, Washington, D.C.

Agenda

10:00 a.m.

About the National Foundation for Infectious Diseases (NFID) and the Richard J. Duma/NFID Annual Press Conference and Symposium on Infectious Diseases
Robert A. Whitney, Jr., D.V.M.
National Foundation for Infectious Diseases

10:05 a.m.

Technological Advances in the Rapid Detection of Bioweapons and Emerging Infectious Agents
Scott P. Layne, MD
University of California, LA
Los Angeles, CA

10:25 a.m.

Questions and Answers

10:30 a.m.

Community Acquired Antimicrobial Resistance: From Emerging Threat to Reality
Stuart B. Levy, MD
Tufts University School of Medicine
Boston, MA

10:50 a.m.

Questions and Answers

10:55 a.m.

The Anthrax Attack on the United States: The Investigation and Ongoing Preparedness Efforts
Michael T. Osterholm, PhD, MPH
Director, Center for Infectious Disease Research and Policy
Professor, School of Public Health
University of Minnesota

11:15 a.m.

Questions and Answers

11:20 a.m.

Ensuring a Stable United States Vaccine Supply - Issues and Potential Solutions
Lance E. Rodewald, M.D.
Director, Immunization Services Division
National Immunization Program
Centers for Disease Control and Prevention
Atlanta, GA

11:40 a.m.

Questions and Answers

11:45 a.m.

Panel Discussion
Moderator--Richard J. Duma, M.D., Ph.D.
Halifax Medical Center
Daytona Beach, Florida

Each panelist will be asked for his/her prediction about late breaking infectious disease news for 2003, followed by questions from the audience.

12:00 p.m.

Lunch with the Press

1:00 p.m.

Adjournment

Presented by the National Foundation for Infectious Diseases with the support of unrestricted educational grants from:

Aventis Pasteur
Aventis Pharmaceuticals, Inc.
Biotechnology Industry Organization
Cubist Pharmaceuticals, Inc.
GlaxoSmithKline